290 related articles for article (PubMed ID: 29519353)
1. Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum.
Kranenburg G; de Jong PA; Bartstra JW; Lagerweij SJ; Lam MG; Ossewaarde-van Norel J; Risseeuw S; van Leeuwen R; Imhof SM; Verhaar HJ; de Vries JJ; Slart RHJA; Luurtsema G; den Harder AM; Visseren FLJ; Mali WP; Spiering W
J Am Coll Cardiol; 2018 Mar; 71(10):1117-1126. PubMed ID: 29519353
[TBL] [Abstract][Full Text] [Related]
2. Etidronate halts systemic arterial calcification in pseudoxanthoma elasticum.
Bartstra JW; de Jong PA; Kranenburg G; Wolterink JM; Isgum I; Wijsman A; Wolf B; den Harder AM; Mali WPTM; Spiering W
Atherosclerosis; 2020 Jan; 292():37-41. PubMed ID: 31756632
[TBL] [Abstract][Full Text] [Related]
3. The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene.
Li Q; Sundberg JP; Levine MA; Terry SF; Uitto J
Cell Cycle; 2015; 14(7):1082-9. PubMed ID: 25607347
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish enpp1 mutants exhibit pathological mineralization, mimicking features of generalized arterial calcification of infancy (GACI) and pseudoxanthoma elasticum (PXE).
Apschner A; Huitema LF; Ponsioen B; Peterson-Maduro J; Schulte-Merker S
Dis Model Mech; 2014 Jul; 7(7):811-22. PubMed ID: 24906371
[TBL] [Abstract][Full Text] [Related]
5. Etidronate prevents, but does not reverse, ectopic mineralization in a mouse model of pseudoxanthoma elasticum (
Li Q; Kingman J; Sundberg JP; Levine MA; Uitto J
Oncotarget; 2018 Jul; 9(56):30721-30730. PubMed ID: 30112102
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and severity of arterial calcifications in pseudoxanthoma elasticum (PXE) compared to hospital controls. Novel insights into the vascular phenotype of PXE.
Kranenburg G; de Jong PA; Mali WP; Attrach M; Visseren FL; Spiering W
Atherosclerosis; 2017 Jan; 256():7-14. PubMed ID: 27940376
[TBL] [Abstract][Full Text] [Related]
7. The effect of etidronate on choroidal neovascular activity in patients with pseudoxanthoma elasticum.
Risseeuw S; van Leeuwen R; Imhof SM; de Jong PA; Mali WPTM; Spiering W; Ossewaarde-van Norel J
PLoS One; 2020; 15(10):e0240970. PubMed ID: 33079965
[TBL] [Abstract][Full Text] [Related]
8. Early arterial calcification does not correlate with bone loss in pseudoxanthoma elasticum.
Martin L; Hoppé E; Kauffenstein G; Omarjee L; Navasiolava N; Henni S; Willoteaux S; Leftheriotis G
Bone; 2017 Oct; 103():88-92. PubMed ID: 28658601
[TBL] [Abstract][Full Text] [Related]
9. Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6(-/-) mice-potential for treatment of pseudoxanthoma elasticum.
Li Q; Larusso J; Grand-Pierre AE; Uitto J
Clin Transl Sci; 2009 Dec; 2(6):398-404. PubMed ID: 20443931
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates: from softening water to treating PXE.
Moore SN; Tanner SB; Schoenecker JG
Cell Cycle; 2015; 14(9):1354-5. PubMed ID: 25894689
[No Abstract] [Full Text] [Related]
11. Vascular Mineralization in Pseudoxanthoma Elasticum: Etidronate to the Rescue?
Uitto J; Li Q
J Am Coll Cardiol; 2018 Mar; 71(10):1127-1129. PubMed ID: 29519354
[No Abstract] [Full Text] [Related]
12. Oral supplementation of inorganic pyrophosphate in pseudoxanthoma elasticum.
Kozák E; Fülöp K; Tőkési N; Rao N; Li Q; Terry SF; Uitto J; Zhang X; Becker C; Váradi A; Pomozi V
Exp Dermatol; 2022 Apr; 31(4):548-555. PubMed ID: 34758173
[TBL] [Abstract][Full Text] [Related]
13. Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC).
Ferrante EA; Cudrici CD; Rashidi M; Fu YP; Huffstutler R; Carney K; Chen MY; St Hilaire C; Smith K; Bagheri H; Katz JD; Ferreira CR; Gahl WA; Boehm M; Brofferio A
Vasc Med; 2024 Jun; 29(3):245-255. PubMed ID: 38568107
[TBL] [Abstract][Full Text] [Related]
14. Arterial stiffening and thickening in patients with pseudoxanthoma elasticum.
Kranenburg G; Visseren FLJ; de Borst GJ; de Jong PA; Spiering W;
Atherosclerosis; 2018 Mar; 270():160-165. PubMed ID: 29432933
[TBL] [Abstract][Full Text] [Related]
15. Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification.
Jacobs IJ; Li Q
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894722
[TBL] [Abstract][Full Text] [Related]
16. Pseudoxanthoma elasticum with prominent arterial calcifications evoking CD73 deficiency.
Devriese M; Legrand A; Courtois MC; Jeunemaitre X; Albuisson J
Vasc Med; 2019 Oct; 24(5):461-464. PubMed ID: 31164056
[TBL] [Abstract][Full Text] [Related]
17. Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum.
Lefthériotis G; Abraham P; Le Corre Y; Le Saux O; Henrion D; Ducluzeau PH; Prunier F; Martin L
J Vasc Surg; 2011 Nov; 54(5):1390-4. PubMed ID: 21723076
[TBL] [Abstract][Full Text] [Related]
18. Pseudoxanthoma Elasticum as a Paradigm of Heritable Ectopic Mineralization Disorders: Pathomechanisms and Treatment Development.
Li Q; van de Wetering K; Uitto J
Am J Pathol; 2019 Feb; 189(2):216-225. PubMed ID: 30414410
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Inflammation and Calcification in Pseudoxanthoma Elasticum Arteries and Skin with 18F-FluroDeoxyGlucose and 18F-Sodium Fluoride Positron Emission Tomography/Computed Tomography Imaging: The GOCAPXE Trial.
Omarjee L; Mention PJ; Janin A; Kauffenstein G; Pabic EL; Meilhac O; Blanchard S; Navasiolava N; Leftheriotis G; Couturier O; Jeannin P; Lacoeuille F; Martin L
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33120982
[TBL] [Abstract][Full Text] [Related]
20. Restricting dietary magnesium accelerates ectopic connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6(-/-) ).
Jiang Q; Uitto J
Exp Dermatol; 2012 Sep; 21(9):694-9. PubMed ID: 22897576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
